Healthcare

Pfizer (NYSE:PFE) noted the FDA approved Tukysa, known generically as tucatinib, as first-line maintenance treatment in HER2-favorable breast cancer. The supporting figure is progression-free survival of 24.9 months versus 16.3 months, an 8.6-month gap by simple arithmetic on two released numbers. Progression-free survival measures …

Alignment Healthcare (NASDAQ:ALHC) was indicated to be down 23.08% in the October 9, 2026 premarket session, using a displayed price of USD 8.71 and a market value approximately USD 1.81 billion on the screener. Released reports link the drop to the Centers for Medicare …

Exchange market data for October 8, 2026 demonstrated a group of substantial gainers. Pacira advanced approximately 44%, Fly-E 83%, Jianzhi Education 77%, Xiao-I 46% and Haemonetics 17.5%. Surrozen (NASDAQ:SRZN) advanced 11.2% to 27.97 and was grouped with them, alongside a 16.4% move in Cable …

The clearest catalyst of the group is a government ratings decision. Humana (NYSE:HUM) increased 14.82% in premarket activity on October 9, 2026 on a quoted price of USD 387.12 and a marketCapitalizationof approximately USD 46.49 billion. The Centers for Medicare and Medicaid Services released …

Humana (NYSE:HUM) increased approximately 15% in premarket activity on October 9, 2026, according to a movers list. Different recaps give 12% after-hours, 14.95% premarket and 16.5%, a spread that reflects timing and venue. The file does not name the catalyst, so none is claimed. …

Humana (NYSE:HUM) rose approximately 15% during premarket dealings on October 9, 2026, according to a movers list. Different recaps give 12% in after-hours trading, 14.95% premarket and 16.5%, which is a spread explained by timing and venue. The file does not name the catalyst, …

Atrium is the only name with a same-week financing. Atrium Therapeutics (NASDAQ:RNA) declined 3.15% in premarket activity on October 9, 2026 on a displayed price of USD 8.26. On October 8 the issuer announced a privatePlacementof approximately USD 50 million: 5,170,384 shares at USD …